DYAX CORP Stock: price and insider trades · United States · SEC (Form 4)Track the DYAX CORP stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 22 January 2016 (Disposition). Among the most active insiders: Christensen Gustav. Every trade is accessible without an account.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 January 2016
All Executives85 Thresholds0 Prospectus0 Other0
Declarations 85 total
● CMO & EVP, R&D · Executives · 22 Jan 2016
208,602 shares Common Stock SEC:0000908662-16-000425:0
● General Counsel & EVP · Executives · 22 Jan 2016
331,528 shares Common Stock SEC:0000908662-16-000426:0
1,016,762 shares Common Stock SEC:0000908662-16-000428:0
100 shares Common Stock SEC:0000908662-16-000428:1
● EVP & Chief Commercial Officer · Executives · 22 Jan 2016
13,750 shares Common Stock SEC:0000908662-16-000427:0
133,333 shares Common Stock SEC:0000908662-16-000431:0
● CEO and President · Executives · 22 Jan 2016
2,447,622 shares Common Stock SEC:0000908662-16-000430:0
● Former director · Executives · 22 Jan 2016
200,970 shares Common Stock SEC:0000908662-16-000432:0
232,440 shares Common Stock SEC:0000908662-16-000433:0
55,041 shares Common Stock SEC:0000908662-16-000434:0
539,805 shares Common Stock SEC:0000908662-16-000434:1
997,336 shares Common Stock SEC:0000908662-16-000434:2
5,021 shares Common Stock SEC:0000908662-16-000434:3
131,305 shares Common Stock SEC:0000908662-16-000435:0
137,433 shares Common Stock SEC:0000908662-16-000436:0
● EVP & Chief Financial Officer · Executives · 22 Jan 2016
751,975 shares Common Stock SEC:0000908662-16-000437:0
● EVP & Chief Financial Officer · Executives · 22 Jan 2016
15,000 shares Common Stock SEC:0000908662-16-000437:1
80,000 shares Common Stock SEC:0000908662-16-000438:0
◇ Director · Executives · 15 Jan 2016
25,000 shares Common Stock SEC:0000908662-16-000403:0
◇ Director · Executives · 15 Jan 2016
75,000 shares Common Stock SEC:0000908662-16-000403:1
◇ Director · Executives · 15 Jan 2016
33,333 shares Common Stock SEC:0000908662-16-000403:2
◇ Director · Executives · 14 Jan 2016
6,000 shares Common Stock SEC:0000908662-16-000402:0
◇ Director · Executives · 14 Jan 2016
75,000 shares Common Stock SEC:0000908662-16-000402:1
◇ Director · Executives · 14 Jan 2016
75,000 shares Common Stock SEC:0000908662-16-000402:2
◇ Director · Executives · 14 Jan 2016
8,107 shares Common Stock SEC:0000908662-16-000402:3
25 of 85 declarations
Load more (60 remaining) 关于 DYAX CORP DYAX CORP 是一家在 XNAS 市场上市的公司,专注于开发罕见疾病的治疗方法。它主要集中于遗传性血管性水肿疾病的疗法。